scholarly journals Plasmablastic Lymphoma Mimicking Osteomyelitis of Femur in an Immunocompetent Individual: A Case Report

Cureus ◽  
2022 ◽  
Author(s):  
Sheza Malik ◽  
Abdullah Zaki ◽  
Muhammad Usman Shabbir ◽  
Taimoor Hussain
2021 ◽  
Vol 9 ◽  
pp. 2050313X2110349
Author(s):  
Brett D Edwards ◽  
Ranjani Somayaji ◽  
Dina Fisher ◽  
Justin C Chia

Mycobacterium elephantis was first described when isolated from an elephant that succumbed to lung abscess. However, despite this namesake, it is not associated with animals and has been described most often as a probable colonizer rather than pathogen in humans with chronic lung disease. In this report, we describe the first case of lymphocutaneous infection from M. elephantis, likely as a result of cutaneous inoculation with contaminated soil. This offers further evidence to its capabilities as a pathogen. We provide a review of the limited prior reports of M. elephantis and outline the available in vitro data on efficacy of various antimycobacterial agents.


2013 ◽  
Vol 51 (7) ◽  
pp. 774-778 ◽  
Author(s):  
Sushruta Kathuria ◽  
Malini Rajinder Capoor ◽  
Sachin Yadav ◽  
Avninder Singh ◽  
V. Ramesh

Oral Surgery ◽  
2021 ◽  
Author(s):  
Marta Aparecida Alberton Nuernberg ◽  
Gabriela Lopes‐Santos ◽  
Cristiane Furuse ◽  
Victor Ângelo Martins Montalli ◽  
Leticia Helena Theodoro ◽  
...  

Author(s):  
Vanessa Milani ◽  
Nara Rúbia Pereira De Siqueira ◽  
Diego Antônio Costa Arantes ◽  
Marcio Tadashi Tino ◽  
Henrique Moura De Paula ◽  
...  

2017 ◽  
Vol 8 (1) ◽  
pp. 29 ◽  
Author(s):  
Sudharani Chintagunta ◽  
Geetakiran Arakkal ◽  
SudhaV Damarla ◽  
AkshayK Vodapalli

2018 ◽  
Vol 2018 ◽  
pp. 1-5 ◽  
Author(s):  
Anthi Bouchla ◽  
Sotirios G. Papageorgiou ◽  
Zoi Tsakiraki ◽  
Eirini Glezou ◽  
George Pavlidis ◽  
...  

Plasmablastic lymphoma (PBL) is a rare, aggressive type of B-cell non-Hodgkin lymphoma with the vast majority of patients responding poorly to treatment or progressing shortly thereafter. Cyclophosphamide-doxorubicin-vincristine-prednisolone (CHOP) or CHOP-like regimens have disappointing results in this setting. We report a case of PBL arising in a previously diagnosed myelodysplastic/myeloproliferative (MDS/MPN) with ring sideroblasts and thrombocytopenia (RS-T), HIV-negative patient treated with the combination of CHOP and bortezomib. The patient achieved complete metabolic response, which has lasted one year, longer by far than would have been expected with the sole use of CHOP.


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Seweryn Bialasiewicz ◽  
Tania P. S. Duarte ◽  
Son H. Nguyen ◽  
Vichitra Sukumaran ◽  
Alexandra Stewart ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document